ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

AICR Increasing Funds for Research, Education, Supports Successful Symposium

November 7, 1986

Tri-Institutional Stem Cell Initiative Funds Grants.

August 4, 2006

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

November 29, 1974